Upgrade to SI Premium - Free Trial

Nkarta (NKTX)

2.74 -0.12 (4.20%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/6/26)

Latest Headlines

After CAR-T, the Next Frontier in Cancer Immunotherapy May Belong to a Different Immune Cell June 12, 2026 8:10 AM - StreetInsider Form 8-K Nkarta, Inc. For: Jun 10 June 11, 2026 4:59 PM - SEC Filing Form 4 Nkarta, Inc. For: Jun 10 Filed by: Shah Rajeev M. June 11, 2026 4:31 PM - SEC Filing Form 4 Nkarta, Inc. For: Jun 10 Filed by: Behbahani Ali June 11, 2026 4:27 PM - SEC Filing Form 4 Nkarta, Inc. For: Jun 10 Filed by: George Simeon June 11, 2026 4:21 PM - SEC Filing Form 4 Nkarta, Inc. For: Jun 10 Filed by: Vratsanos George June 11, 2026 4:11 PM - SEC Filing Form 4 Nkarta, Inc. For: Jun 10 Filed by: Scheiner Zachary June 11, 2026 4:08 PM - SEC Filing Form 4 Nkarta, Inc. For: Jun 10 Filed by: PATTERSON LEONE D June 11, 2026 4:08 PM - SEC Filing Form 4 Nkarta, Inc. For: Jun 10 Filed by: Dybbs Michael June 11, 2026 4:08 PM - SEC Filing Form 4 Nkarta, Inc. For: Jun 10 Filed by: Thedinga Angela June 11, 2026 4:07 PM - SEC Filing Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet June 8, 2026 9:01 AM - Globe NewsWire Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet June 8, 2026 9:01 AM - StreetInsider Form SCHEDULE 13D/A Nkarta, Inc. Filed by: New Enterprise Associates 15, L.P. May 19, 2026 4:04 PM - SEC Filing Nkarta, Inc. (NKTX) Misses Q1 EPS by 2c May 12, 2026 5:14 PM - StreetInsider Form 10-Q Nkarta, Inc. For: Mar 31 May 12, 2026 4:10 PM - SEC Filing Form 8-K Nkarta, Inc. For: May 12 May 12, 2026 4:05 PM - SEC Filing Nkarta Reports First Quarter 2026 Financial Results and Corporate Highlights May 12, 2026 4:01 PM - StreetInsider Form ARS Nkarta, Inc. For: Dec 31 April 23, 2026 7:06 PM - SEC Filing Form DEFA14A Nkarta, Inc. April 23, 2026 7:06 PM - SEC Filing Form DEF 14A Nkarta, Inc. For: Jun 10 April 23, 2026 7:06 PM - SEC Filing Nkarta gets FDA approval for outpatient dosing of autoimmune therapy April 15, 2026 4:01 PM - StreetInsider Nkarta Announces FDA Agreement on Outpatient Dosing of NKX019 in Autoimmune Disease, Expanding Access to Community Rheumatology Centers April 15, 2026 4:01 PM - StreetInsider Nkarta to Participate in Needham Virtual Healthcare Conference April 9, 2026 7:00 AM - StreetInsider Form EFFECT Nkarta, Inc. April 6, 2026 6:01 AM - SEC Filing Form 424B5 Nkarta, Inc. April 3, 2026 5:29 PM - SEC Filing Nkarta Inc. (NKTX) PT Lowered to $12 at Mizuho March 30, 2026 8:56 AM - StreetInsider Nkarta Inc. (NKTX) PT Raised to $11 at Needham March 26, 2026 7:34 AM - StreetInsider Nkarta (NKTX) Reiterated at Buy by Stifel; Estimates Largely Unchanged March 26, 2026 7:19 AM - StreetInsider Form 8-K Nkarta, Inc. For: Mar 25 March 26, 2026 6:01 AM - SEC Filing Form S-3 Nkarta, Inc. March 25, 2026 5:23 PM - SEC Filing Nkarta, Inc. (NKTX) Misses Q4 EPS by 6c March 25, 2026 5:04 PM - StreetInsider Form 10-K Nkarta, Inc. For: Dec 31 March 25, 2026 4:09 PM - SEC Filing Form 8-K Nkarta, Inc. For: Mar 25 March 25, 2026 4:04 PM - SEC Filing Nkarta Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights March 25, 2026 4:01 PM - StreetInsider Full Article List